✦ LIBER ✦

A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time

✍ Scribed by Noguchi, Masanori; Moriya, Fukuko; Suekane, Shigetaka; Ohnishi, Rei; Matsueda, Satoko; Sasada, Tetsuro; Yamada, Akira; Itoh, Kyogo

Book ID: 121578202
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 600 KB
Volume: 13
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-13-613

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunological evaluation of personalized

Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer

✍ Hirotsugu Uemura; Kiyohide Fujimoto; Takashi Mine; Shigeya Uejima; Marco A. De V 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB

Phase II study of personalized peptide v

Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy

✍ Masanori Noguchi; Fukuko Moriya; Shigetaka Suekane; Kei Matsuoka; Gaku Arai; Sat 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

674 DELAYED PSA RESPONSES IN PERSONALIZE

674 DELAYED PSA RESPONSES IN PERSONALIZED PEPTIDE VACCINATION FOR CASTRATE-RESISTANT PROSTATE CANCER PATIENTS PHASE II STUDY

✍ Noguchi, Masanori; Moriya, Fukuko; Suekane, Shigetaka; Matsuoka, Kei; Matsueda, 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 122 KB

Ipilimumab and a poxviral vaccine target

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

✍ Ravi A Madan; Mahsa Mohebtash; Philip M Arlen; Matteo Vergati; Myrna Rauckhorst; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 138 KB

S207 Comparing prostate specific antigen

S207 Comparing prostate specific antigen doubling time and prostate specific antigen velocity as predictors of prognosis and survival in hormone-resistant prostate cancer patients

✍ Sabur, V.; Demirtas, A.; Baydilli, N.; Akinsal, E.C.; Demirci, D.; Ekmekcioglu, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 85 KB

900 OPEN-LABEL PHASE II STUDY EVALUATING

900 OPEN-LABEL PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF PERSONALIZED PEPTIDE VACCINATION (PPV) IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER(CRPC)

✍ Noguchi, Masanori; Moriya, Fukuko; Suekane, Shigetaka; Matsuoka, Kei; Arai, Gaku 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 54 KB